G-CSF therapy with mobilization of bone marrow stem cells for myocardial recovery after acute myocardial infarction-A relevant treatment?

Experimental Hematology

Volumn 36, Issue 6, 2008, Pages 681-686

  Ripa, Rasmus Sejersten ^a   Kastrup, Jens ^a  

^a University of Copenhagen   (Denmark)

Author keywords

[No Author keywords available]

Indexed keywords

GRANULOCYTE COLONY STIMULATING FACTOR; PLACEBO;

ACUTE HEART INFARCTION; ATHEROSCLEROSIS; CELL TYPE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONVALESCENCE; DOSE RESPONSE; DRUG INDICATION; DRUG MECHANISM; DRUG SAFETY; HEART FUNCTION; HEART PROTECTION; HEMATOPOIETIC STEM CELL TRANSPLANTATION; HUMAN; MEDICAL LITERATURE; NONHUMAN; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; RESTENOSIS; REVASCULARIZATION; REVIEW; ST SEGMENT ELEVATION; STEM CELL MOBILIZATION; TREATMENT FAILURE; TREATMENT OUTCOME;

ANIMALS; BONE MARROW TRANSPLANTATION; CARDIOTONIC AGENTS; CLINICAL TRIALS AS TOPIC; DISEASE MODELS, ANIMAL; GRANULOCYTE COLONY-STIMULATING FACTOR; HEMATOPOIETIC STEM CELL MOBILIZATION; HUMANS; MYOCARDIAL INFARCTION; TREATMENT OUTCOME;

EID: 43049159983     PISSN: 0301472X     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.exphem.2008.01.010     Document Type: Review

References (51)

1. Orlic D., Kajstura J., Chimenti S., et al. Bone marrow cells regenerate infarcted myocardium. Nature 410 (2001) 701-705
2. Orlic D., Kajstura J., Chimenti S., et al. Mobilized bone marrow cells repair the infarcted heart, improving function and survival. Proc Natl Acad Sci U S A 98 (2001) 10344-10349
3. Ohtsuka M., Takano H., Zou Y., et al. Cytokine therapy prevents left ventricular remodeling and dysfunction after myocardial infarction through neovascularization. FASEB J 18 (2004) 851-853
4. Minatoguchi S., Takemura G., Chen X.H., et al. Acceleration of the healing process and myocardial regeneration may be important as a mechanism of improvement of cardiac function and remodeling by postinfarction granulocyte colony-stimulating factor treatment. Circulation 109 (2004) 2572-2580
5. Iwanaga K., Takano H., Ohtsuka M., et al. Effects of G-CSF on cardiac remodeling after acute myocardial infarction in swine. Biochem Biophys Res Commun 325 (2004) 1353-1359
6. Ieishi K., Nomura M., Kawano T., et al. The effect of G-CSF in a myocardial ischemia reperfusion model rat. J Med Invest 54 (2007) 177-183
7. Avalos B.R. Molecular analysis of the granulocyte colony-stimulating factor receptor. Blood 88 (1996) 761-777
8. Anderlini P., Donato M., Chan K.W., et al. Allogeneic blood progenitor cell collection in normal donors after mobilization with filgrastim: the M.D. Anderson Cancer Center experience. Transfusion 39 (1999) 555-560
9. Nagasawa T., Kikutani H., and Kishimoto T. Molecular cloning and structure of a pre-B-cell growth-stimulating factor. Proc Natl Acad Sci U S A 91 (1994) 2305-2309
10. Deichmann M., Kronenwett R., and Haas R. Expression of the human immunodeficiency virus type-1 coreceptors CXCR-4 (fusin, LESTR) and CKR-5 in CD34+ hematopoietic progenitor cells. Blood 89 (1997) 3522-3528
11. Petit I., Szyper-Kravitz M., Nagler A., et al. G-CSF induces stem cell mobilization by decreasing bone marrow SDF-1 and up-regulating CXCR4. Nat Immunol 3 (2002) 687-694
12. Semerad C.L., Christopher M.J., Liu F., et al. G-CSF potently inhibits osteoblast activity and CXCL12 mRNA expression in the bone marrow. Blood 106 (2005) 3020-3027
13. Kawabata K., Ujikawa M., Egawa T., et al. A cell-autonomous requirement for CXCR4 in long-term lymphoid and myeloid reconstitution. Proc Natl Acad Sci U S A 96 (1999) 5663-5667
14. Flomenberg N., DiPersio J., and Calandra G. Role of CXCR4 chemokine receptor blockade using AMD3100 for mobilization of autologous hematopoietic progenitor cells. Acta Haematol 114 (2005) 198-205
15. Nervi B., Link D.C., and DiPersio J.F. Cytokines and hematopoietic stem cell mobilization. J Cell Biochem 99 (2006) 690-705
16. Levesque J.P., Hendy J., Takamatsu Y., Williams B., Winkler I.G., and Simmons P.J. Mobilization by either cyclophosphamide or granulocyte colony-stimulating factor transforms the bone marrow into a highly proteolytic environment. Exp Hematol 30 (2002) 440-449
17. Levesque J.P., Takamatsu Y., Nilsson S.K., Haylock D.N., and Simmons P.J. Vascular cell adhesion molecule-1 (CD106) is cleaved by neutrophil proteases in the bone marrow following hematopoietic progenitor cell mobilization by granulocyte colony-stimulating factor. Blood 98 (2001) 1289-1297
18. Heissig B., Hattori K., Dias S., et al. Recruitment of stem and progenitor cells from the bone marrow niche requires MMP-9 mediated release of kit-ligand. Cell 109 (2002) 625-637
19. Levesque J.P., Liu F., Simmons P.J., et al. Characterization of hematopoietic progenitor mobilization in protease-deficient mice. Blood 104 (2004) 65-72
20. Fujita J., Mori M., Kawada H., et al. Administration of granulocyte colony-stimulating factor after myocardial infarction enhances the recruitment of hematopoietic stem cell-derived myofibroblasts and contributes to cardiac repair. Stem Cells 25 (2007) 2750-2759
21. Harada M., Qin Y., Takano H., et al. G-CSF prevents cardiac remodeling after myocardial infarction by activating the Jak-Stat pathway in cardiomyocytes. Nat Med 11 (2005) 305-311
22. Hilfiker-Kleiner D., Hilfiker A., Fuchs M., et al. Signal transducer and activator of transcription 3 is required for myocardial capillary growth, control of interstitial matrix deposition, and heart protection from ischemic injury. Circ Res 95 (2004) 187-195
23. Yamauchi-Takihara K., and Kishimoto T. A novel role for STAT3 in cardiac remodeling. Trends Cardiovasc Med 10 (2000) 298-303
24. Ueda K., Takano H., Hasegawa H., et al. Granulocyte colony stimulating factor directly inhibits myocardial ischemia-reperfusion injury through Akt-endothelial NO synthase pathway. Arterioscler Thromb Vasc Biol 26 (2006) e108-e113
25. Boneberg E.M., Hareng L., Gantner F., Wendel A., and Hartung T. Human monocytes express functional receptors for granulocyte colony-stimulating factor that mediate suppression of monokines and interferon-gamma. Blood 95 (2000) 270-276
26. Hartung T. Anti-inflammatory effects of granulocyte colony-stimulating factor. Curr Opin Hematol 5 (1998) 221-225
27. Suárez de Lezo J., Torres A., Herrera I., et al. [Effects of stem-cell mobilization with recombinant human granulocyte colony stimulating factor in patients with percutaneously revascularized acute anterior myocardial infarction]. Rev Esp Cardiol 58 (2005) 253-261
28. Kuethe F., Figulla H.R., Herzau M., et al. Treatment with granulocyte colony-stimulating factor for mobilization of bone marrow cells in patients with acute myocardial infarction. Am Heart J 150 (2005) 115
29. Valgimigli M., Rigolin G.M., Cittanti C., et al. Use of granulocyte-colony stimulating factor during acute myocardial infarction to enhance bone marrow stem cell mobilization in humans: clinical and angiographic safety profile. Eur Heart J 26 (2005) 1838-1845
30. Leone A.M., Galiuto L., Garramone B., et al. Usefulness of granulocyte colony-stimulating factor in patients with a large anterior wall acute myocardial infarction to prevent left ventricular remodeling (the RIGENERA study). Am J Cardiol 100 (2007) 397-403
31. Kang H.J., Kim H.S., Koo B.K., et al. Intracoronary infusion of the mobilized peripheral blood stem cell by G-CSF is better than mobilization alone by G-CSF for improvement of cardiac function and remodeling: 2-year follow-up results of the Myocardial Regeneration and Angiogenesis in Myocardial Infarction with G-CSF and Intra-Coronary Stem Cell Infusion (MAGIC Cell) 1 trial. Am Heart J 153 (2007) 237-238
32. Takano H., Hasegawa H., Kuwabara Y., et al. Feasibility and safety of granulocyte colony-stimulating factor treatment in patients with acute myocardial infarction. Int J Cardiol (2007) 31;122:41-47
33. Ince H., Petzsch M., Kleine H.D., et al. Preservation from left ventricular remodeling by front-integrated revascularization and stem cell liberation in evolving acute myocardial infarction by use of granulocyte-colony-stimulating factor (FIRSTLINE-AMI). Circulation 112 (2005) 3097-3106
34. Ripa R.S., Jørgensen E., Wang Y., et al. Stem cell mobilization induced by subcutaneous granulocyte-colony stimulating factor to improve cardiac regeneration after acute ST-elevation myocardial infarction: result of the double-blind, randomized, placebo-controlled stem cells in myocardial infarction (STEMMI) trial. Circulation 113 (2006) 1983-1992
35. Ellis S.G., Penn M.S., Bolwell B., et al. Granulocyte colony stimulating factor in patients with large acute myocardial infarction: results of a pilot dose-escalation randomized trial. Am Heart J 152 (2006) 1051.e9-e14
36. Zohlnhöfer D., Ott I., Mehilli J., et al. Stem cell mobilization by granulocyte colony-stimulating factor in patients with acute myocardial infarction: a randomized controlled trial. JAMA 295 (2006) 1003-1010
37. Engelmann M.G., Theiss H.D., Hennig-Theiss C., et al. Autologous bone marrow stem cell mobilization induced by granulocyte colony-stimulating factor after subacute ST-segment elevation myocardial infarction undergoing late revascularization: final results from the G-CSF-STEMI (Granulocyte Colony-Stimulating Factor ST-Segment Elevation Myocardial Infarction) trial. J Am Coll Cardiol 48 (2006) 1712-1721
38. Schächinger V., Erbs S., Elsasser A., et al. Intracoronary bone marrow-derived progenitor cells in acute myocardial infarction. N Engl J Med 355 (2006) 1210-1221
39. Wang Y., Johnsen H.E., Mortensen S., et al. Changes in circulating mesenchymal stem cells, stem cell homing factor, and vascular growth factors in patients with acute ST elevation myocardial infarction treated with primary percutaneous coronary intervention. Heart 92 (2006) 768-774
40. Ip J.E., Wu Y., Huang J., Zhang L., Pratt R.E., and Dzau V.J. Mesenchymal stem cells use integrin beta1 not CXC chemokine receptor 4 for myocardial migration and engraftment. Mol Biol Cell 18 (2007) 2873-2882
41. Wang Y., Ripa R.S., Jorgensen E., Hesse B., Mortensen S., and Kastrup J. Mobilization of haematopoietic and non-haematopoietic cells by granulocyte-colony stimulating factor and vascular endothelial growth factor gene therapy in patients with stable severe coronary artery disease. Scand Cardiovasc J 41 (2007) 397-404
42. Ripa R.S., Haack-Sorensen M., Wang Y., et al. Bone marrow derived mesenchymal cell mobilization by granulocyte-colony stimulating factor after acute myocardial infarction: results from the Stem Cells in Myocardial Infarction (STEMMI) trial. Circulation 116 (2007) I24-I30
43. Honold J., Lehmann R., Heeschen C., et al. Effects of granulocyte colony simulating factor on functional activities of endothelial progenitor cells in patients with chronic ischemic heart disease. Arterioscler Thromb Vasc Biol 26 (2006) 2238-2243
44. Dlubek D., Drabczak-Skrzypek D., and Lange A. Low CXCR4 membrane expression on CD34(+) cells characterizes cells mobilized to blood. Bone Marrow Transplant 37 (2006) 19-23
45. Lehrke S., Mazhari R., Durand D.J., et al. Aging impairs the beneficial effect of granulocyte colony-stimulating factor and stem cell factor on post-myocardial infarction remodeling. Circ Res 99 (2006) 553-560
46. Ripa R.S., Wang Y., Jørgensen E., Johnsen H.E., Grande P., and Kastrup J. Safety of bone-marrow stem cell mobilisation induced by granulocyte-colony stimulating factor: Clinical 30 days blinded results from the stem cells in myocardial infarction (STEMMI) trial. Heart Drug 5 (2005) 177-182
47. Kang H.J., Kim H.S., Zhang S.Y., et al. Effects of intracoronary infusion of peripheral blood stem-cells mobilised with granulocyte-colony stimulating factor on left ventricular systolic function and restenosis after coronary stenting in myocardial infarction: the MAGIC cell randomised clinical trial. Lancet 363 (2004) 751-756
48. Steinwender C., Hofmann R., Kammler J., et al. Effects of peripheral blood stem cell mobilization with granulocyte-colony stimulating factor and their transcoronary transplantation after primary stent implantation for acute myocardial infarction. Am Heart J 151 (2006) 1296.e7-e13
49. Jørgensen E., Ripa R.S., Helqvist S., et al. In-stent neo-intimal hyperplasia after stem cell mobilization by granulocyte-colony stimulating factor Preliminary intracoronary ultrasound results from a double-blind randomized placebo-controlled study of patients treated with percutaneous coronary intervention for ST-elevation myocardial infarction (STEMMI Trial). Int J Cardiol 111 (2006) 174-177
50. Menasche P., Hagege A.A., Vilquin J.T., et al. Autologous skeletal myoblast transplantation for severe postinfarction left ventricular dysfunction. J Am Coll Cardiol 41 (2003) 1078-1083
51. Kuhlmann M.T., Kirchhof P., Klocke R., et al. G-CSF/SCF reduces inducible arrhythmias in the infarcted heart potentially via increased connexin43 expression and arteriogenesis. J Exp Med 203 (2006) 87-97